Abstract
Coronavirus disease 2019 (COVID-19) is a kind of viral pneumonia which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The emergence of SARS-CoV-2 has been marked as the third introduction of a highly pathogenic coronavirus into the human population after the severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome coronavirus (MERS-CoV) in the twenty-first century. In this minireview, we provide a brief introduction of the general features of SARS-CoV-2 and discuss current knowledge of molecular immune pathogenesis, diagnosis and treatment of COVID-19 on the base of the present understanding of SARS-CoV and MERS-CoV infections, which may be helpful in offering novel insights and potential therapeutic targets for combating the SARS-CoV-2 infection.
| Original language | English |
|---|---|
| Pages (from-to) | 102-108 |
| Number of pages | 7 |
| Journal | Journal of Pharmaceutical Analysis |
| Volume | 10 |
| Issue number | 2 |
| DOIs | |
| State | Published - Apr 2020 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Coronavirus
- MERS-CoV
- Pathogenesis
- SARS-CoV
- SARS-CoV-2
Fingerprint
Dive into the research topics of 'Molecular immune pathogenesis and diagnosis of COVID-19'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver